Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Yule

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Archives of Disease in Childhood|December 22, 2000
Low grade astrocytomas in the West of Scotland 1987-96: treatment, outcome, and cognitive functioningS M Yule, T A Hide, M Cranney, et al.
Cancer Genetics and Cytogenetics|June 1, 1992
Chronic myelomonocytic leukemia with t(13;14) in a childN Bown, S M Yule, J Evans, et al.
BMJ (Clinical Research Ed.)|April 24, 1999
Cyclosporin neurotoxicity after chemotherapyD A Tweddle, K P Windebank, Q C Hewson, et al.
Pediatric Hematology and Oncology|March 1, 1994
Occurrence of seminoma and dysgerminoma in father and daughterS M Yule, P J Dawes, A J Malcolm, et al.
Cancer Chemotherapy and Pharmacology|April 26, 2001
Cyclophosphamide metabolism in children following a 1-h and a 24-h infusionS M Yule, L Price, M Cole, et al.
Bone Marrow Transplantation|August 24, 1999
Cyclophosphamide metabolism in children with Fanconi's anaemiaS M Yule, L Price, M Cole, et al.
Cancer Genetics and Cytogenetics|April 1, 1995
Solid alveolar rhabdomyosarcoma with a t(2;13)S M Yule, N Bown, A J Malcolm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 1997
High-dose cyclophosphamide for poor-prognosis and recurrent pediatric brain tumors: a dose-escalation studyS M Yule, N K Foreman, C Mitchell, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Comparison of continuous infusion and bolus administration of ifosfamide in childrenA V Boddy, S M Yule, R Wyllie, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Intrasubject variation in children of ifosfamide pharmacokinetics and metabolism during repeated administrationA V Boddy, S M Yule, R Wyllie, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Archives of Disease in Childhood|December 22, 2000
Low grade astrocytomas in the West of Scotland 1987-96: treatment, outcome, and cognitive functioningS M Yule, T A Hide, M Cranney, et al.
Cancer Genetics and Cytogenetics|June 1, 1992
Chronic myelomonocytic leukemia with t(13;14) in a childN Bown, S M Yule, J Evans, et al.
BMJ (Clinical Research Ed.)|April 24, 1999
Cyclosporin neurotoxicity after chemotherapyD A Tweddle, K P Windebank, Q C Hewson, et al.
Pediatric Hematology and Oncology|March 1, 1994
Occurrence of seminoma and dysgerminoma in father and daughterS M Yule, P J Dawes, A J Malcolm, et al.
Cancer Chemotherapy and Pharmacology|April 26, 2001
Cyclophosphamide metabolism in children following a 1-h and a 24-h infusionS M Yule, L Price, M Cole, et al.
Bone Marrow Transplantation|August 24, 1999
Cyclophosphamide metabolism in children with Fanconi's anaemiaS M Yule, L Price, M Cole, et al.
Cancer Genetics and Cytogenetics|April 1, 1995
Solid alveolar rhabdomyosarcoma with a t(2;13)S M Yule, N Bown, A J Malcolm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 1997
High-dose cyclophosphamide for poor-prognosis and recurrent pediatric brain tumors: a dose-escalation studyS M Yule, N K Foreman, C Mitchell, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Comparison of continuous infusion and bolus administration of ifosfamide in childrenA V Boddy, S M Yule, R Wyllie, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Intrasubject variation in children of ifosfamide pharmacokinetics and metabolism during repeated administrationA V Boddy, S M Yule, R Wyllie, et al.
Pageof 3